Related Experiment Video
Updated: Oct 29, 2025

Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations
Published on: July 21, 2023
Pharmacogenomics in Cardiovascular Diseases
1Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, Gainesville, Florida.
Abstract:
Cardiovascular pharmacogenomics is the study and identification of genomic markers that are associated with variability in cardiovascular drug response, cardiovascular drug-related outcomes, or cardiovascular drug-related adverse events. This overview presents an introduction and historical background to cardiovascular pharmacogenomics, and a protocol for designing a cardiovascular pharmacogenomics study. Important considerations are also included for constructing a cardiovascular pharmacogenomics phenotype, designing the replication or validation strategy, common statistical approaches, and how to put the results in context with the cardiovascular drug or cardiovascular disease under investigation. © 2021 Wiley Periodicals LLC. Basic Protocol: Designing a cardiovascular pharmacogenomics study.
Related Concept Videos
Pharmacodynamics in Geriatric Patients: Effects of Age
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Factors Affecting Drug Response: Overview
Cardiovascular Drugs: Classification based on Therapeutic Indications
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...

